COPENHAGEN, Denmark, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced financial results ...

Northern Kentucky lawmaker wants overhaul of bill meant to protect income that some Kentucky hospitals say is essential for ...

Replimune's innovative cancer therapies, strong cash reserves, and FDA support position it to disrupt oncology markets. Click ...

Rocket Pharmaceuticals, Inc.'s innovative therapies show promise after FDA setbacks. With potential $1B+ markets, RCKT offers ...

UnitedHealthcare supplies Medicare Supplement plans to over four million members across the U.S., according to the company.

Sonoma County commits settlement funds from opioid manufacturers to address its drug crisis, with a focus on treatment and ...

Astellas has invested heavily in novel technologies that are not necessarily the most successful or popular in the industry.

The drug supply is constantly evolving, and some experts suggest that a “fourth wave” of the opioid epidemic is underway, in which illicit fentanyl is more frequently mixed with other drugs.

The U.S. Food and Drug Administration (FDA) has granted Fast Track Designation (FTD) to CUSP06, a Cadherin-6 targeting ...

The ad goes on to tout Hims & Hers' weight loss drugs as less expensive alternatives to medications like Ozempic and Wegovy, ...

A child would need to eat 9,000 cookies in a day to approach harmful levels of pesticide or naturally occurring heavy metals.